Yup, its all about Inavir now.
I've plotted what Inavir's sales might look like for the March Qtr (to be reported mid May) based on the market split being the same as the previous quarter, and based on no production capacity issues, etc.
$150-160M or thereabouts in Japan... nothing to be sneezed at.
I would say that would trigger any milestone payment out of the water.
- Forums
- ASX - By Stock
- BTA
- Ann: Relenza March Quarter Royalty
Ann: Relenza March Quarter Royalty , page-10
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online